Pentaerythrityltetrabromide

Catalog No.: 
ACELYC702
CAS No.: 
3229-00-3
Molecular Formula: 
C5H8Br4
Molecular Weight: 
387.73
Pentaerythrityltetrabromide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g98%$52.00In stockInquiry
100g98%$163.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NamePentaerythrityltetrabromide
IUPAC Name1,3-dibromo-2,2-bis(bromomethyl)propane
MDL No.MFCD00000210
Molecular FormulaC5H8Br4
Molecular Weight387.73
SMILESBrCC(CBr)(CBr)CBr
InChI KeyOYSVBCSOQFXYHK-UHFFFAOYSA-N
SynonymMFCD00000210 | Pentaerythrit-tetrabromid | SY050984 | P0752 | 1,3-Benzenedisulfonicacid, 4-hydroxy- | 1,3-Dibromo-2,2-bis(bromomethyl)propane | AKOS005146228 | FT-0634733 | Propane,3-dibromo-2,2-bis(bromomethyl)- | SCHEMBL432313 | Pentaerythrityl tetrabro
CAS No.3229-00-3
PubChem CID76701

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACELYC702 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOVKL251 route compound structure diagram
    ACOVKL2511522-92-5In Stock
  4. Then
  5. ACELYC702 route product structure diagram
    ACELYC7023229-00-3In Stock
Inquiry

2. ACELYC702 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACELYC702 route product structure diagram
    ACELYC7023229-00-3In Stock
Inquiry

3. ACELYC702 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACELYC702 route product structure diagram
    ACELYC7023229-00-3In Stock
Inquiry

Comments (0)